To Medved, the founder and CEO of OurCrowd – one of Israel’s most active venture capital companies – it’s not all about IPOs and exits and making money. It’s also – perhaps even primarily – about helping humanity.
Read more here.
To Medved, the founder and CEO of OurCrowd – one of Israel’s most active venture capital companies – it’s not all about IPOs and exits and making money. It’s also – perhaps even primarily – about helping humanity.
Read more here.
![[OncoHost in PR Newswire] OncoHost announces interim results from PROPHETIC trial, multicenter assessment of NSCLC patient response to immunotherapy](https://blog.gold.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
